Molecular drugs are far from perfect. As biotechnology develops, researchers are finding that human cells may be used in the treatment of certain diseases, and in some cases offer benefits over traditional therapies. This is the theory behind Encellin, a San Francisco-based company that hopes to change the treatment for Type I diabetes.
Encellin’s (Read more...)